参考文献
[1] Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62(4):e1-e50.
[2] Bassetti M, Righi E, Ansaldi F, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality[J]. Intensive Care Med, 2015, 41(9):1601-1610.
[3] Bassetti M, Marchetti M, Chakrabarti A, et al.A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts[J]. Intensive Care Med,2013, 39(12):2092-2106.
[4] Cornely OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patient[J]. ClinMicrobiol Infect, 2012, 18(Suppl 7):19-37.
[5] Vergidis P, Clancy CJ, Shields RK, et al. Intra-abdominal candidiasis: The importance of early source control and antifungal treatment[J]. PLoS One, 2016, 11(4):e0153247.
[6] Lichtenstern C, Herold C, Mieth M, et al. Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis[J]. Mycoses,2015, 58(7):399-407.
[7] Andes DR, Safdar N, Baddley JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant- Associated Infection Surveillance Network(TRANSNET)[J]. Transpl Infect Dis,2016, 18(6):921-931.
[8] de Ruiter J, Weel J, Manusama E, et al. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis[J]. Infection,2009, 37(6):522-527.
[9] Aguilar G, Delgado C, Corrales I, et al. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study[J]. BMC Res Notes,2015, 29(8):491.
[10] Panackal AA, Williamson PR. The promise of immunogenomics at the bedside: Genetic risk of intra-abdominal candidasis[J]. Crit Care Med,2014, 42(4):1019-1020.
[11] Cheng S, Clancy CJ, Hartman DJ, et al. Candida glabrata Intra-Abdominal Candidiasis Is Characterized by Persistence within the Peritoneal Cavity and Abscesses[J]. Infect Immun,2014, 82(7):3015-3022.
[12] Zappella N, Desmard M, Chochillon C, et al. Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery[J]. Clin Microbiol Infect, 2015, 21(9):853.e1-3.
[13] Lagunes L, Rey-Pérez A, Martín-Gómez MT, et al. Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(1):95-104.
[14] Fiore M; LeoneS. Spontaneous fungal peritonitis: Epidemiology, current evidence and future prospective[J]. World J Gastroenterol, 2016, 22(34):7742-7747.
[15] Alexopoulou A, Vasilieva L, Agiasotelli D, et al. Fungal infections in patients with cirrhosis[J]. J Hepatol, 2015, 63(4):1043-1045.
[16] Bucsics T, Schwabl P, Mandorfer M, et al. Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP)[J]. J Hepatol,2016, 64(6):1452-1454.
[17] Alexopoulou A, Vasilieva L, Agiasotelli D, et al. Reply to ''Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis”[J]. J Hepatol,2016, 64(6):1454-1455.
[18] Bremmer DN, Garavaglia JM, Shields RK. Spontaneous fungal peritonitis: a devastating complication of cirrhosis[J]. Mycoses, 2015, 58(7):387-393.
[19] Cheng S, Clancy CJ, Xu W, et al. Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis[J]. J Infect Dis,2013, 208(9):1529-1537.
[20] Colombo J, Arena A, Codazzi D, et al. Intra-abdominal candidiasis and probiotics: we know little but it's time to try[J]. Intensive Care Med, 2014, 40(2):297-298.
[21] Wójtowicz A, Tissot F, Lamoth F, et al. Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal candida infection in high-risk surgical ICU patients[J]. Crit Care Med, 2014, 42(4):304-308.
[22] León C, Ruiz-Santana S, Saavedra P, et al. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions[J]. Crit Care, 2016, 20(1):149.
[23] Worasilchai N, Leelahavanichkul A, Kanjanabuch T, et al. (1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study[J]. Med Mycol, 2015, 53(4):338-346.
[24] Tissot F, Lamoth F, Hauser PM, et al. β-glucanantigenemia anticipates diagnosis of blood culture–negative intraabdominalcandidiasis[J]. Am J RespirCrit Care Med, 2013, 188(9):1100-1109.
[25] Montravers P, Leroy O, Eckmann C. Intra-abdominal candidiasis: it’s still a long way to get unquestionable data[J]. Intensive Care Med, 2015, 41(9):1682-1684.
[26] Montravers P, Dupont H, Eggimann P. Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis[J]. Intensive Care Med, 2013, 39(12): 2226-2230.
[27] Kumar S, Bansal A, Chakrabarti A, et al. Evaluation of efficacy of probiotics in prevention of Candida colonization in a PICU—a randomized controlled trial[J]. Crit Care Med, 2013, 41(2):565-572.
[28] Timsit JF, Azoulay E, Schwebel C, et al. EMPIRICUS Trial Group.Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: The EMPIRICUS Randomized Clinical Trial[J]. JAMA, 2016, 316(15):1555-1564.
[29] Wolfgang Knitsch, Jean-Louis Vincent, Stefan Utzolino, et al. A Randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections[J]. Clin Infect Dis, 2015, 61(11):1671-1678.
[30] Arvanitis M, Mylonakis E. Characteristics, clinical relevance, and the role of echinocandins in fungal–bacterial interactions[J]. Clin Infect Dis, 2015, 61(Suppl 6):S630-S634.